11/06/2025
Any Opinions? Good or Bad?
Trump Announces Weight-Loss Drug Discounts as Novo Nordisk Executive Collapses in Oval Office
Last updated
33 minutes ago
President Donald Trump announced agreements with Eli Lilly and Novo Nordisk to drastically reduce prices on GLP-1 drugs like Ozempic and Wegovy, allowing Medicare and Medicaid to cover them for obesity patients with copays as low as $50 monthly. Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz projected unrealistic national weight loss figures of 135 billion pounds by the 2026 midterms, which experts debunked. During the Thursday Oval Office event, Novo Nordisk executive Gordon Findlay fainted, received immediate aid, and was confirmed stable by the White House.